Free Essay

Pityriasis Rosea

In:

Submitted By norbenbendejo
Words 1730
Pages 7
-------------------------------------------------
Pityriasis rosea
From Wikipedia, the free encyclopedia Pityriasis rosea | Classification and external resources | Pityriasis rosea on human torso | ICD-10 | L42 | ICD-9 | 696.3 | DiseasesDB | 24698 | MedlinePlus | 000871 | eMedicine | derm/335 emerg/426ped/1815 | MeSH | D017515 |
Pityriasis rosea (also known as pityriasis rosea Gibert[1]) is a skin rash. It is benign but may inflict substantial discomfort in certain cases.[2] Classically, it begins with a single "herald patch" lesion, followed in 1 or 2 weeks by a generalized body rash lasting about 6 weeks.[3][4][5] Contents [hide] * 1 Signs and symptoms * 2 Causes * 3 Diagnosis * 4 Treatment * 5 Prognosis * 6 Epidemiology * 7 See also * 8 References * 9 External links |
-------------------------------------------------
[edit]Signs and symptoms

Pityriasis rosea on human torso
The symptoms of this condition include: * An upper respiratory tract infection may precede all other symptoms in as many as 69% of patients[6] * A single, 2- to 10-cm oval red "herald" patch appears, classically on the abdomen.[7][5]Occasionally, the "herald" patch may occur in a 'hidden' position (in the armpit, for example) and not be noticed immediately. The "herald" patch may also appear as a cluster of smaller oval spots, and be mistaken for acne. Rarely, it does not become present at all.[7] * 7-14 days after the herald patch, large patches of pink or red, flaky, oval-shaped rash appear on the torso.[7] In 6% of cases an inverse distribution may occur, with rash mostly on the extremities.[8] The more numerous oval patches generally spread widely across the chest first, following the rib-line in a characteristic "christmas-tree" distribution.[7] Small, circular patches may appear on the back and neck several days later. It is unusual for lesions to form on the face, but they may appear on the cheeks or at the hairline. * About one in four people with PR suffer from mild to severe symptomatic itching. (Moderate itching due to skin over-dryness is much more common, especially if soap is used to cleanse the affected areas.) The itching is often non-specific, and worsens if scratched. This tends to fade as the rash develops and does not usually last through the entire course of the disease.[7] * The rash may be accompanied by low-grade fever, headache, nausea and fatigue. Over-the-counter medications can help manage these.[7]
-------------------------------------------------
[edit]Causes
The cause of pityriasis rosea is not certain, but its clinical presentation and immunologic reactions suggest a viral infection as a cause.[9][10] Also, HHV-7 is frequently found in healthy individuals, so its etiologic role is controversial.[9]
-------------------------------------------------
[edit]Diagnosis

A herald patch of pityriasis rosea which started before the rest of the lesion as failed treatment with antifungal medication
Experienced practitioners may make the diagnosis clinically.[5] If the diagnosis is in doubt, tests may be performed to rule out similar conditions such as Lyme disease, ringworm, guttate psoriasis, nummular or discoid eczema, drug eruptions, other viral exanthems,[5] and especially secondary syphilis.[11] A biopsy of the lesions will show extravasatederythrocytes within dermal papillae and dyskeratotic cells within the dermis.[5]
A set of validated diganostic criteria for pityriasis rosea [12][13]is as follows:
A patient is diagnosed as having pityriasis rosea if:
1. On at least one occasion or clinical encounter, he / she has all the essential clinical features and at least one of the optional clinical features, and 2. On all occasions or clinical encounters related to the rash, he / she does not have any of the exclusional clinical features.
The essential clinical features are: 1. Discrete circular or oval lesions, 2. Scaling on most lesions, and 3. Peripheral collarette scaling with central clearance on at least two lesions.
The optional clinical features are: 1. Truncal and proximal limb distribution, with less than 10% of lesions distal to mid-upper-arm and mid-thigh, 2. Orientation of most lesions along skin cleavage lines, and 3. A herald patch (not necessarily the largest) appearing at least two days before eruption of other lesions, from history of the patient or from clinical observation.
The exclusional clinical features are:
1. Multiple small vesicles at the centre of two or more lesions, 2. Two or more lesions on palmar or plantar skin surfaces, and 3. Clinical or serological evidence of secondary syphilis.
-------------------------------------------------
[edit]Treatment
No treatment is usually required.
Oral antihistamines or topical steroids may be used to decrease itching.[5] Steroids do provide relief from itching, and improve the appearance of the rash, but they also cause the new skin that forms (after the rash subsides) to take longer to match the surrounding skin color. While no scarring has been found to be associated with the rash, itching and scratching should be avoided. It's possible that scratching can make itching worse and an itch-scratch cycle may develop with regular scratching (that is, you itch more because you scratch, so you scratch more because you itch, and so on). Irritants such as soaps with fragrances, hot water, wool, and synthetic fabrics should be avoided; a soap containing moisturizers (such as goat's milk) may be used, however, and any generic moisturizer can help to manage over-dryness. Calamine lotion may be soothing to the skin and reduce itching. Emulsifiers should be used instead of soaps, as emulsifiers are gentler on the skin and include cleansers, eliminating the need for soap.
Direct sunlight makes the lesions resolve more quickly.[5] According to this principle, medical treatment with ultraviolet light has been used to hasten resolution,[14] though studies disagree whether it decreases itching[14] or not.[15] UV therapy is most beneficial in the first week of the eruption.[14]
-------------------------------------------------
[edit]Prognosis
In most patients, the condition lasts only a matter of weeks; in some cases it can last longer (up to six months). The disease resolves completely without long-term effects. Two percent of patients have recurrence.[16][17]
-------------------------------------------------
[edit]Epidemiology
The overall prevalence of PR in the United States has been estimated to be 0.13% in men and 0.14% in women. It most commonly occurs between the ages of 10 and 35.[5] It is more common in spring.[5]
PR is not viewed as contagious,[18][2] though there have been reports of small epidemics in fraternity houses and military bases, schools and gyms.[5]
-------------------------------------------------
[edit]See also * Pityriasis circinata - a localized form of pityriasis rosea that affects the axillae and groin * Pityriasis - for list of similarly named flaky skin conditions * List of cutaneous conditions
-------------------------------------------------
[edit]References 1. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0. 2. ^ a b "Pityriasis rosea". American Osteopathic College of Dermatology. Retrieved 26 Jan 2010. 3. ^ Freedberg; et al (2003). Fitzpatrick's Dermatology in General Medicine (6th ed.). McGraw-Hill. p. 445. ISBN 0-07-138076-0 4. ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology (10th ed.). Saunders. pp. 208–9. ISBN 0-7216-2921-0. 5. ^ a b c d e f g h i j Habif, Thomas P (2004). Clinical Dermatology: A Clinical Guide to Diagnosis and Therapy (4th ed.). Mosby. pp. 246–8.ISBN 0-323-01319-8 6. ^ Sharma, P (2000). J Am Acad Dermatol 42 (2 pt 1): 241. 7. ^ a b c d e f "Pityriasis rosea". American Academy of Dermatology. 2000, 2003. Retrieved 2009-06-04. 8. ^ Tay, Y; Goh, C (1999). "One-year review of pityriasis rosea at the National Skin Centre, Singapore". Ann Acad Med Singapore 28 (6). 9. ^ a b Medscape > Pityriasis Rosea Author: Robert A Allen, MD; Chief Editor: Dirk M Elston, MD. Updated: Feb 13, 2009 10. ^ Cynthia M. Magro; A. Neil Crowson; Martin C. Mihm (2007). The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin. John Wiley and Sons. pp. 36–. ISBN 978-0-471-69598-1. Retrieved 10 November 2010. 11. ^ Horn T, Kazakis A (1987). "Pityriasis rosea and the need for a serologic test for syphilis". Cutis 39 (1): 81–2. PMID 3802914. 12. ^ Chuh AAT. Diagnostic criteria for pityriasis rosea – a prospective case control study for assessment of validity. J Eur Acad Dermatol Venereol 2003; 17: 101-3. 13. ^ Chuh A, Zawar V, Law M, Sciallis G. Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. Infect Dis Rep 2012: 4: e12 14. ^ a b c Arndt, KA; Paul, BS; Stern, RS; Parrish, JA (1983). "Treatment of pityriasis rosea with UV radiation". Arch Dermatol 119 (5): 381–2.doi:10.1001/archderm.119.5.381. PMID 6847217. 15. ^ Leenutaphong V, Jiamton S (1995). "UVB phototherapy for pityriasis rosea: a bilateral compatison study". J Am Acad Dermatol 33 (6): 996–9. doi:10.1016/0190-9622(95)90293-7. PMID 7490372. 16. ^ Kempf, W; et al, V; Kleinhans, M; Burg, G; Panizzon, RG; Campadelli-Fiume, G; Nestle, FO (1999). "Pityriasis rosea is not associated with Human herpesvirus 7". Arch Dermatol 135 (9): 1070–2. doi:10.1001/archderm.135.9.1070. PMID 10490111. 17. ^ Chuang, T-Y; et al (1982). "Pityriasis rosea in Rochester, Minnesota, 1969 to 1978: a 10-year epidemiologic study". J Am Acad Dermatol 7: 80. 18. ^ "Pityriasis rosea". DERMAdoctor.com. Retrieved 26 Jan 2010.
-------------------------------------------------
[edit]External links * DermNet viral/pityriasis-rosea * American Academy of Dermatology - Pityriasis Rosea * HealthInPlainEnglish - Pityriasis rosea * American Osteopathic College of Dermatology [show] * v * t * eDiseases of the skin and appendages by morphology | |

[show] * v * t * ePapulosquamous disorders (L40–L45, 696–697) | |
Categories:
* Ailments of unknown etiology * Papulosquamous hyperkeratotic cutaneous conditions * Create account * Log in * Article * Talk * Read * Edit * View history
-------------------------------------------------
Top of Form

Bottom of Form * Main page * Contents * Featured content * Current events * Random article * Donate to Wikipedia
Interaction
* Help * About Wikipedia * Community portal * Recent changes * Contact Wikipedia
Toolbox
Print/export
Languages
* العربية * Български * Català * Dansk * Deutsch * Español * Français * Italiano * עברית * Lietuvių * Nederlands * 日本語 * Norsk (bokmål)‎ * Polski * Português * Русский * Suomi * Türkçe * This page was last modified on 9 November 2012 at 00:24. * Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of Use for details.
Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. * Contact us * Privacy policy * About Wikipedia * Disclaimers * Mobile view * *

Similar Documents

Premium Essay

Knowledge Discovery in Medical Databases Leveraging Data Mining

...Abstract Abstract The goal of this master’s thesis is to identify and evaluate data mining algorithms which are commonly implemented in modern Medical Decision Support Systems (MDSS). They are used in various healthcare units all over the world. These institutions store large amounts of medical data. This data may contain relevant medical information hidden in various patterns buried among the records. Within the research several popular MDSS’s are analysed in order to determine the most common data mining algorithms utilized by them. Three algorithms have been identified: Naïve Bayes, Multilayer Perceptron and C4.5. Prior to the very analyses the algorithms are calibrated. Several testing configurations are tested in order to determine the best setting for the algorithms. Afterwards, an ultimate comparison of the algorithms orders them with respect to their performance. The evaluation is based on a set of performance metrics. The analyses are conducted in WEKA on five UCI medical datasets: breast cancer, hepatitis, heart disease, dermatology disease, diabetes. The analyses have shown that it is very difficult to name a single data mining algorithm to be the most suitable for the medical data. The results gained for the algorithms were very similar. However, the final evaluation of the outcomes allowed singling out the Naïve Bayes to be the best classifier for the given domain. It was followed by the Multilayer Perceptron and the C4.5. Keywords: Naïve Bayes, Multilayer...

Words: 35271 - Pages: 142